ALK three-lens brief
Evidence-based stock research on ALK. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Underperforming SPY by 16.4pp over 30 days.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 16.4pp over 30 days.
- P/E of 94 — priced for high growth; little margin of safety.
- Analyst mean target $59.34 — 48% above current (16 analysts).
- Negative free cash flow last quarterly (-$23.75M).
ALK closed at $40.11 (-0.62%) as of 2026-09-11. Market cap: $4.47B. P/E (trailing) 94.1. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $59.34 — 48% above current (16 analysts).. Concerns: 50-day MA below 200-day MA (death-cross regime); price below both.; underperforming SPY by 16.4pp over 30 days.. Last quarter: Revenue $4.07B, net income -$76.00M, free cash flow -$23.75M.
Why three lenses on ALK, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALKacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ALK" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALK brief"></iframe>